-+ 0.00%
-+ 0.00%
-+ 0.00%

Armata Pharma director Daniel Gilmer files initial beneficial ownership statement

PUBT·04/28/2026 20:34:46
Listen to the news
Armata Pharma director Daniel Gilmer files initial beneficial ownership statement
  • Armata Pharmaceuticals director Daniel Gilmer filed an initial Form 3 statement dated April 24, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-050386), on April 28, 2026, and is solely responsible for the information contained therein.